氧化供体增加静脉血流和胎儿氧化在胎儿生长限制. 一个试点研究研究
Daniele Farsetti1, Francesca Pometti2, Barbara Vasapollo1
1Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy; Department of Obstetrics and Gynecology, Policlinico Casilino, Rome, Italy.
Placenta
|May 8, 2024
概括
用氧化供体和口服液治疗改善了孕妇和胎儿在胎儿生长限制的怀孕中的血液动力学. 这种方法导致带静脉血流增加和更好的胎儿大脑节省,表明有益的结果.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 心血管生理学心血管生理学
背景情况:
- 胎儿生长限制 (FGR) 对母亲和胎儿的健康构成重大风险.
- 目前的FGR管理策略往往侧重于监测和及时交付.
- 需要进行治疗干预,以改善FGR怀孕中的血液动力学参数.
研究的目的:
- 研究一氧化供体和口服液对FGR怀孕中母亲和胎儿血液动力学的影响.
- 评估这种联合治疗对静脉血流和脑胎位比率的影响.
- 评估治疗对出生体重和孕前发病率的影响.
主要方法:
- 一项前性研究,涉及30名正常压力参与者,早期患有FGR.
- 15名参与者接受过皮的甘三酸盐和口服液 (治疗组).
- 15名参与者作为未经治疗的对照组,在基线和2周内进行血液动力学评估.
主要成果:
- 治疗组在母亲的血液动力学方面表现出显著的改善.
- 胎儿血液动力学显示,脉直径增加,血液流动增加,血液流动对治疗组的胎儿估计体重进行了校正.
- 脑胎盘比率在治疗组增加,在未治疗组下降,在治疗组中出生体重百分比较高,孕前率较低.
结论:
- 使用氧化供体和口服液的联合治疗改善了FGR中的母体血液动力学.
- 这种干预增强了胎儿的血液循环,由脉流量增加和改善胎儿大脑节省所证明.
- 这种治疗有望改善胎儿的结果,并减少FGR怀孕中的孕前.
相关概念视频
Fetal Circulation
944
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
944
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Antihypertensive Drugs: Vasodilators
508
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
508


